Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
0.3700
+0.0120 (3.35%)
At close: May 12, 2025, 4:00 PM
0.3610
-0.0090 (-2.43%)
After-hours: May 12, 2025, 7:38 PM EDT
Bolt Biotherapeutics Market Cap
Bolt Biotherapeutics has a market cap or net worth of $14.19 million as of May 12, 2025. Its market cap has decreased by -67.93% in one year.
Market Cap
14.19M
Enterprise Value
-7.93M
1-Year Change
-67.93%
Ranking
Category
Stock Price
$0.37
Market Cap Chart
Since the IPO on February 5, 2021, Bolt Biotherapeutics's market cap has decreased from $690.43M to $14.19M, a decrease of -97.95%. That is a compound annual growth rate of -59.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 14.19M | -30.73% |
| Dec 31, 2024 | 20.48M | -51.84% |
| Dec 29, 2023 | 42.52M | -13.15% |
| Dec 30, 2022 | 48.96M | -73.20% |
| Dec 31, 2021 | 182.69M | -73.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |